UNSPSC 50501515: Retinol

This classification denotes a fat-soluble vitamin with the molecular formula C20H30O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier G2SH0XKK91, chemically known as 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-nona-2,4,6,8-tetraen-1-ol but more generally known as retinol, which bears U.S. National Institutes of Health Compound Identifier 1071. The European Medicines Agency schedules Retinol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10292MIG.

UNSPSC 50501515 Retinol, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities—naloxone procurement, direct-to-manufacturer prescription planning, and generic multi-source pharmaceutical distribution—involve pharmaceutical products and systems substantially outside retinol's scope as a vitamin A derivative used in dermatological and nutritional contexts. The mismatch suggests either miscoding in the state and local procurement systems or that retinol purchases, if occurring, are not driving current solicitation activity.

Activity under this code shows no recent opportunities directly soliciting retinol or retinol-containing products. The Seminole County, Florida IFB for naloxone and drug deactivation systems (due Jul 26, 2023), the Texas Health and Human Services Commission RFI on direct-to-manufacturer prescriptions (due Apr 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance RFP for generic pharmaceuticals and OTC products (due Mar 26, 2026) represent the tagged opportunities but contain no retinol procurement language or requirements. Absent concrete evidence of retinol-specific demand in recent state and local solicitations, the code appears inactive for business development purposes at present.